NASDAQ: XWEL
XWELL, Inc.CIK 0001410428 · SIC 7200 · Personal Services
XWELL is a global wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa®, XpresTest®, and Naples Wax Center®. As of the date of this Annual Report on Form 10-K, XWELL currently has three… About this business →
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade XWEL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
revenue $6.6M, net income -$11.2M. XWELL raises, eliminates going-concern warning, but G&A expenses surge 76%
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.
XWELL announces fiscal year 2025 financial results and corporate update
2 material changes detected. Sign up free to read the summary.
revenue $29.2M, net income -$17.0M. XWELL posts 14% revenue decline, impairs Naples Wax goodwill; Series H financing lifts going-concern doubt
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 14, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
(In thousands, except share and per share data)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Revenue, net | ||||
| Services | 6,531 | 6,905 | 12,596 | 13,325 |
| Products | 614 | 784 | 1,188 | 1,387 |
| Total revenue, net | 7,145 | 7,689 | 13,784 | 14,712 |
| Cost of sales | ||||
| Labor | 3,037 | 3,912 | 6,011 | 7,879 |
| Occupancy | 606 | 1,238 | 1,367 | 2,372 |
| Products and other operating costs | 554 | 764 | 1,104 | 1,367 |
| Total cost of sales | 4,197 | 5,914 | 8,482 | 11,618 |
| Gross Profit | 2,948 | 1,775 | 5,302 | 3,094 |
| Depreciation and amortization | 163 | 187 | 335 | 353 |
| Loss on disposal of assets, net | 239 | — | 239 | — |
| General and administrative | 4,650 | 4,280 | 12,246 | 8,591 |
| Total operating expenses | 5,052 | 4,467 | 12,820 | 8,944 |
| Operating loss | (2,104) | (2,692) | (7,518) | (5,850) |
| Change in fair value of derivative liabilities | — | 421 | (5,584) | 279 |
| Change in fair value of warrant liability | — | 625 | — | 3,215 |
| Loss on issuance of Series G Preferred Stock | — | — | — | (3,443) |
| Interest income (expense), net | 11 | 147 | (32) | 204 |
| Foreign exchange gain (loss) | 102 | (543) | 179 | (998) |
| Gain on investments, realized and unrealized | 188 | 58 | 166 | 54 |
| Other non-operating expense, net | (29) | (34) | (55) | (67) |
| Loss before income taxes | (1,832) | (2,018) | (12,844) | (6,606) |
| Income tax expense | (51) | (34) | (51) | (34) |
| Net loss | (1,883) | (2,052) | (12,895) | (6,640) |
| Net income attributable to noncontrolling interests | (357) | (217) | (547) | (348) |
| Net loss attributable to XWELL, Inc. | (2,240) | (2,269) | (13,442) | (6,988) |
| Net loss | (1,883) | (2,052) | (12,895) | (6,640) |
| Other comprehensive income (loss) | (41) | 417 | (119) | 606 |
| Comprehensive loss | (1,924) | (1,635) | (13,014) | (6,034) |
| Loss per share | ||||
| Preferred stock dividends | — | (189) | (82) | (257) |
| Preferred stock accretion | — | (583) | — | (1,082) |
| Deemed contribution on Repurchase of Series G Preferred Stock | — | — | 106 | — |
| Net loss attributable to XWELL, Inc. common stockholders | (2,240) | (3,041) | (13,418) | (8,327) |
| Basic and diluted loss per share | (0.26) | (0.56) | (1.69) | (1.56) |
| Weighted-average number of shares outstanding | ||||
| Basic | 8,487,425 | 5,417,271 | 7,944,801 | 5,340,442 |
| Diluted | 8,487,425 | 5,417,271 | 7,944,801 | 5,340,442 |
Condensed Consolidated Balance Sheets (Unaudited)
(In thousands, except share and per share data)
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current assets | ||
| Cash and cash equivalents | 11,778 | 2,617 |
| Marketable securities | — | 7 |
| Accounts receivable, net | 1,824 | 1,560 |
| Inventory | 391 | 509 |
| Other current assets | 1,146 | 1,217 |
| Total current assets | 15,139 | 5,910 |
| Restricted cash | 568 | 251 |
| Property and equipment, net | 1,606 | 1,665 |
| Intangible assets, net | 20 | 101 |
| Operating lease right-of-use assets, net | 836 | 1,039 |
| Security deposits | 2,067 | 2,127 |
| Other assets | 290 | 124 |
| Total assets | 20,526 | 11,217 |
| Current liabilities | ||
| Accounts payable | 1,618 | 2,836 |
| Accrued expenses and other current liabilities | 2,657 | 2,940 |
| Accrued Series G convertible preferred stock redemption payable | — | 538 |
| Current portion of operating lease liabilities | 1,685 | 1,862 |
| Deferred revenue | 708 | 1,126 |
| Convertible senior secured note, net | — | 3,590 |
| Total current liabilities | 6,668 | 12,892 |
| Long-term liabilities | ||
| Derivative liability | — | 3,870 |
| Operating lease liabilities | 5,606 | 7,035 |
| Total liabilities | 12,274 | 23,797 |
| Commitments and contingencies (see Note 8) | ||
| Temporary equity | ||
| Series G Convertible Preferred Stock, $0.01 par value per share and $1,000 stated value per share, 4,000 shares authorized; 0 and 196 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; Liquidation preference of $0 as of June 30, 2026 | — | 224 |
| Equity (deficit) | ||
| Series H Convertible Preferred Stock, $0.01 par value per share and $1,000 stated value per share, 35,000 shares authorized; 31,333 and 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively; Liquidation preference of $31,333 as of June 30, 2026 | — | — |
| Common stock, $0.01 par value per share, 150,000,000 shares authorized; 8,471,766 and 6,071,324 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 84 | 61 |
| Additional paid-in capital | 502,962 | 468,915 |
| Accumulated deficit | (503,139) | (489,697) |
| Accumulated other comprehensive loss | (1,761) | (1,541) |
| Total equity (deficit) attributable to XWELL, Inc. | (1,854) | (22,262) |
| Noncontrolling interests | 10,106 | 9,458 |
| Total equity (deficit) | 8,252 | (12,804) |
| Total liabilities, temporary equity and equity | 20,526 | 11,217 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In thousands)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities | ||
| Net loss | (12,895) | (6,640) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 335 | 353 |
| Unrealized gain on marketable securities | — | (33) |
| Foreign currency remeasurement (gain) loss | (179) | 998 |
| Gain on lease termination | (501) | (401) |
| Loss on disposal of assets, net | 239 | — |
| Amortization of operating lease right-of-use asset | 158 | 490 |
| Provision for credit losses | (4) | 6 |
| Stock-based compensation | 984 | 682 |
| Non-cash interest expense | 53 | |
| Gain on equity investment | (166) | (20) |
| Change in fair value of derivative liability | 5,584 | (279) |
| Change in fair value of warrant liability | — | (3,215) |
| Loss on issuance of Series G Preferred Stock | — | 3,443 |
| Changes in assets and liabilities: | ||
| Decrease (increase) in inventory | 117 | (59) |
| (Increase) decrease in accounts receivable | (259) | 278 |
| (Decrease) in deferred revenue | (417) | (106) |
| Decrease (increase) in other assets, current and non-current | 96 | (1,013) |
| (Decrease) in other liabilities, current and non-current | (1,196) | (1,287) |
| (Decrease) increase in accounts payable | (1,066) | 239 |
| Net cash used in operating activities | (9,117) | (6,564) |
| Cash flows from investing activities | ||
| Acquisition of property and equipment | (559) | (1,313) |
| Investment in marketable securities | — | (84) |
| Sale of marketable securities | 7 | 4,488 |
| Net cash provided by (used in) investing activities | (552) | 3,091 |
| Cash flows from financing activities | ||
| Payment of Series G Preferred Stock dividends | (76) | (95) |
| Payments for shares withheld on vesting | — | — |
| Payment for Repurchase of preferred stock, convertible notes and warrants | (9,000) | — |
| Proceeds from Series H Preferred Stock in private placement, net of offering costs | 28,269 | 3,745 |
| Net cash provided by financing activities | 19,193 | 3,650 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (46) | 36 |
| Increase in cash, cash equivalents and restricted cash | 9,478 | 213 |
| Cash, cash equivalents, and restricted cash at beginning of the year | 2,868 | 5,301 |
| Cash, cash equivalents, and restricted cash at end of the period | 12,346 | 5,514 |
| Cash paid for | ||
| Income taxes | 51 | 34 |
| Non-cash investing and financing transactions | ||
| Capital expenditures included in accounts payable, accrued expenses and other current liabilities | (125) | 16 |
| Accrual of Series G convertible preferred stock dividends | 82 | 162 |
| Accretion of Series G convertible preferred stock to redemption value | — | 1,082 |
| Initial fair value of warrant liability | — | 5,873 |
| Initial fair value of derivative liability | — | 1,315 |
| Accrued Series G convertible preferred stock redemption payable | — | 829 |
| Reclass of warrant liability upon warrant modification | — | 2,658 |
| Derecognition of right-of-use asset and operating lease liabilities upon termination of lease | 47 | — |
| Lease liability remeasurement due to modification | — | 79 |
| Noncash conversion of Series G convertible preferred stock | 543 | — |
| Deemed dividend on Repurchase of Series G Preferred Stock | 106 | — |
| Fair value of Placement Agent warrants | 7,152 | — |
| Contribution on Repurchase of related party debt, net of warrant repurchase cost | 4,250 | — |
Amounts as printed on the EDGAR/iXBRL face — (In thousands, except share and per share data); (In thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗
About XWELL, Inc.
Source: Item 1 (Business) from the 10-K filed April 1, 2026. Description as filed by the company with the SEC.
ITEM 1. BUSINESS
Overview
XWELL is a global wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa®, XpresTest®, and Naples Wax Center®. As of the date of this Annual Report on Form 10-K, XWELL currently has three reportable operating segments: XpresSpa®, XpresTest® and Naples Wax Center®.
On October 25, 2022, the Company changed its name to XWELL, Inc. (“XWELL” or the “Company”) from XpresSpa Group, Inc. The Company’s common stock, par value $0.01 per share, which had previously been listed under the trading symbol “XSPA” on Nasdaq, now trades under the trading symbol “XWEL”. The Company filed an amended and restated certificate of incorporation with the Delaware Secretary of State on October 24, 2022 (as amended, the “Amended and Restated Certificate”) reflecting the name change. Rebranding to XWELL aligned the Company’s corporate strategy to build a pure-play wellness services company, in both the airport and off-airport marketplaces.
All amounts are in thousands, except share, per share, or as otherwise specifically noted.
XpresSpa
XWELL’s subsidiary, XpresSpa Holdings, LLC (“XpresSpa”) has been a global airport retailer of spa services through its XpresSpa spa locations, offering travelers premium spa services, including massage, nail and skin care, as well as spa and travel products.
As of December 31, 2025, there were 16 domestic XpresSpa locations in total. The Company also had 9 international locations operating as of December 31, 2025, including 2 XpresSpa locations in the Dubai International Airport in the United Arab Emirates, 1 XpresSpa location in the Zayad International Airport in Abu Dhabi, United Arab Emirates, 2 XpresSpa locations in the Schiphol Amsterdam Airport in the Netherlands and 4 XpresSpa locations in the Istanbul Airport in Turkey.
Read full description ↓
Treat, which is operating through XWELL’s subsidiary Treat, Inc. (“Treat”) is a wellness brand that provides access to wellness services for travelers at on-site centers. In April 2024, the decision was made to close the location in the Salt Lake City International Airport. In the first quarter of 2025, the decision was made to convert the final remaining Treat location at JFK International Airport in New York City to an XWELL location. As of December 31, 2025 all Treat locations have been converted to XWELL.
XpresTest
The Company, in partnership with certain COVID-19 testing partners, successfully launched its XpresCheck Wellness Centers, in June of 2020, through its XpresTest, Inc. subsidiary (“XpresTest”), which offered COVID-19 and other medical testing to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. Customs and Border Protection agents during the pandemic. As of December 31, 2023, the Company closed all XpresCheck locations and XpresTest no longer provides diagnostic testing services XpresTest began conducting bio surveillance monitoring with the Centers for Disease Control and Prevention (CDC) in collaboration with Concentric by Ginkgo Bioworks Holdings, Inc. (“Ginkgo Bioworks”) in 2021.
The program was renewed through August 2024. The revenue to XpresTest from such one-year extension totaled approximately $7,044. In January 2024, the program funding and scope were expanded, a revenue increase of $4,000, to an estimated $11,044 in revenue for XpresTest with new collection locations at U.S. international airports and the roll out of multi-pathogen testing across the program. In July 2024, the contract was further amended to extend the time period for services by two weeks (extension period August 12, 2024 to August 25, 2024). An increase of $293 in revenue for the two week extension brought total revenue to $11,337. The program was again extended in August 2024 through February 25,
2025. The funding was expanded with a revenue increase of $3,763, to an estimated $15,100 in revenue for XpresTest. In February 2025, the program was extended through a three-year contract with a total base value of $22,200 over three years, and a maximum ceiling value of $24,800 within the same timeframe.
Naples Wax Center
XWELL’s subsidiary Naples Wax, LLC, d/b/a Naples Wax Centers (“Naples Wax Center” or “Naples Wax”) which was acquired on September 12, 2023, for a purchase price of $1,624, operates a group of upscale hair removal locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. The acquisition of Naples Wax Center is intended to enable us to move beyond our airport client base with a business that can be adapted to a larger wellness platform while also growing our retail footprint to serve our long-term financial goals.
Although we recognize four segments of business, we believe there is opportunity to leverage a segment of our products and services across our platform of brands. Additionally, we are expanding our retail strategy, not only adding more products for sale but aligning those products more efficiently to our service offerings. This product strategy includes, for example, adding muscle relaxation patches to a neck or back massage to continue treatment after the delivery of the service.
We also plan to build our capability for delivering health and wellness services outside of the airport. We believe operating outside of the airport complements our offering and represents the fastest way to scale the XWELL family of brands.
We will be looking to further expand internationally. We believe a strategy for international expansion further advances our ability to expand our other brands including bio surveillance outside of the US.
Our Strategy and Outlook
We believe our company is strategically positioned to capitalize on the growing consumer interest in travel, health, and wellness, as well as the increasing demand for related products and services. Our forward-looking plan focuses on expanding and integrating offerings across our brands, with a key emphasis on unifying airport and off-airport locations under the XWELL brand. This strategic alignment will enable the development of membership programs that provide seamless access to XWELL locations, fostering deeper customer relationships and enhancing brand loyalty. Additionally, a strong customer community will support targeted marketing initiatives and cross-promotional opportunities.
As part of our strategy, we will optimize our airport portfolio to create a leaner, more profitable business while leveraging the high foot traffic of airport locations to build brand recognition. Simultaneously, we will pursue an off-airport growth strategy through acquisitions, particularly in the expanding med spa sector, which includes health, wellness, and beauty services. Our plan includes both developing new locations and acquiring established med spas, strategically expanding XWELL’s presence in key metropolitan areas that align with our existing airport locations. This approach will enhance membership accessibility and strengthen our brand’s reach.
Additionally, our expertise from the XpresTest unit will allow us to expand bio-security services beyond the U.S. through partnerships with government clients. Domestically, we will continue growing our bio-security initiatives in collaboration with government agencies. These strategic efforts will serve as catalysts for future growth, support our international expansion goals, and ensure scalable, long-term success. By optimizing our cost structure, refining our existing operations, and pursuing strategic acquisitions, XWELL is positioning itself for sustainable financial and operational growth while maximizing shareholder value.
Competition
Our domestic units operate within many of the largest and most heavily trafficked airports in the United States. The balance of the domestic market is highly fragmented and is represented largely by small, privately-owned entities. The largest domestic competitor operated 9 locations in 7 airports in the United States.
Our Market
Airport retailers differ significantly from traditional retailers. Unlike traditional retailers, airport retailers benefit from a steady and predictable flow of traffic from a constantly changing customer base. Airport retailers also benefit from “dwell time,” the period after travelers have passed through airport security and before they board an aircraft. For over 21 years, increased security requirements have led travelers to spend more time at the airport. In addition, in anticipation of the long and often stressful security lines, travelers allow for more time to get through security and, as a result, often experience increased downtime prior to boarding. XWELL is uniquely positioned to address this gap focusing on an expedient experience that still allows its customers to escape the hectic confines of the airport.
To take advantage of growing demand for unique travel wellness products, XWELL has made significant investments in a new retail offering that addresses this growing consumer demand. Further, as more airports exchange services for more traditional food and beverage providers, XWELL is positioned to take advantage of passenger demand for healthier and bio-nutrient rich snack and food offerings as part of its grab and go strategy.
The competition for airplane landings has forced airports to lower landing fees, which in turn has necessitated augmenting their retail offerings to offset budget shortfalls. Infrastructure projects at airports across the country, again intended to make an airport more desirable to airlines, require funding from bond issuances that in turn rely upon, in part, the expected minimum rent guarantees and expected income from concessionaires.
Equally as important to the industry growth is XWELL’s flexible, valuable, and desirable retail format and footprint within the airport retail segment. XWELL historically opened multiple locations annually, which have ranged in size from 200 square feet to 2,600 square feet, with a typical size of approximately 800 square feet. XWELL has been able to adapt its operating model to almost any size location available in space constrained airports. This increased flexibility compared to other retail concepts has allowed and will continue to allow XWELL to operate multiple stores within an airport, including in some cases for different concepts.
The acquisition of Naples Wax Center was intended to support the Company’s strategy of expanding out-of-airport locations to diversify its portfolio and reduce reliance on in-airport operations. However, certain Naples Wax Center locations have experienced operating challenges, which resulted in the recognition of impairment charges during the year.
Although we have historically focused our growth on the airport space, our strategy continues to shift with further emphasis on growth outside the airport—in and out of travel focused centers. This shift includes taking our XpresSpa brand out of the airport and into other transit centers such as rail terminals. It also includes growth through acquisition such as Naples Wax Centers where we can apply our wellness pedigree to expand that business from both a location standpoint and from a diversification of products and services standpoint.
Our goal continues to be opportunistic expansion outside the airport and we believe our family of brands will help to serve that growth strategy.
Regulation
Our operations are subject to a range of laws and regulations adopted by national, regional, and local authorities from the various jurisdictions in which we operate, including those relating to, among others, licensing (e.g., massage, nail, and cosmetology), public health and safety and fire codes. Failure to obtain or retain required licenses and approvals, including those related to licensing, public health and safety and fire codes, would adversely affect our operations. Although we have not experienced, and do not anticipate, significant problems obtaining required licenses, permits or approvals, any difficulties, delays or failures in obtaining such licenses, permits or approvals could delay or prevent the opening, or adversely impact the viability, of our operations.
Airport authorities in the United States frequently require that our airport concessions meet minimum Airport Concession Disadvantaged Business Enterprise (“ACDBE”) participation requirements. The Department of Transportation’s (“DOT”) ACDBE program is implemented by recipients of DOT Federal Financial Assistance, including airport agencies that receive federal funding. The ACDBE program is administered by the Federal Aviation Administration (“FAA”), state and
local ACDBE certifying agencies and individual airports. The ACDBE program is designed to help ensure that small firms owned and controlled by socially and economically disadvantaged individuals can compete for airport contracting and concession opportunities in domestic passenger service airports. The ACDBE regulations require that airport recipients establish annual ACDBE participation goals, review the scope of anticipated large prime contracts throughout the year, and establish contract specific ACDBE participation goals. We generally meet the contract specific goals through an agreement providing for co-ownership of the retail location with a disadvantaged business enterprise. Frequently, and within the guidelines issued by the FAA, we may lend money to ACDBEs in connection with concession agreements in order to help the ACDBE fund the capital investment required under a concession agreement. The rules and regulations governing the certification of ACDBE participation in airport concession agreements are complex, and ensuring ongoing compliance is costly and time consuming. Further, if we fail to comply with the minimum ACDBE participation requirements in our concession agreements, we may be held responsible for breach of contract, which could result in the termination of a concession agreement and monetary damages. See “